1.Gangjee A, Namjoshi OA, Yu J, Ihnat MA, Thorpe JE, Warnke LA.. (2008) Design, synthesis and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agents., 16 (10):[PMID:18467105][10.1016/j.bmc.2008.04.019]
2.Li R, Pourpak A, Morris SW.. (2009) Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach., 52 (16):[PMID:19610618][10.1021/jm9002395]
3.Gangjee A, Zhao Y, Raghavan S, Ihnat MA, Disch BC.. (2010) Design, synthesis and evaluation of 2-amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors and antiangiogenic agents., 18 (14):[PMID:20558072][10.1016/j.bmc.2010.05.049]
4.Gangjee A, Zaware N, Raghavan S, Yang J, Thorpe JE, Ihnat MA.. (2012) N⁴-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-d]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: design, synthesis, and in vivo evaluation., 20 (7):[PMID:22370340][10.1016/j.bmc.2012.01.029]
